TXG logo

10x Genomics (TXG) Cash and cash equivalents

annual cash & cash equivalents:

$344.07M-$15.22M(-4.24%)
December 31, 2024

Summary

  • As of today (May 29, 2025), TXG annual cash & cash equivalents is $344.07 million, with the most recent change of -$15.22 million (-4.24%) on December 31, 2024.
  • During the last 3 years, TXG annual cash & cash equivalents has fallen by -$243.38 million (-41.43%).
  • TXG annual cash & cash equivalents is now -48.15% below its all-time high of $663.60 million, reached on December 31, 2020.

Performance

TXG Cash and cash equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTXGbalance sheet metrics

quarterly cash & cash equivalents:

$377.06M+$32.99M(+9.59%)
March 31, 2025

Summary

  • As of today (May 29, 2025), TXG quarterly cash & cash equivalents is $377.06 million, with the most recent change of +$32.99 million (+9.59%) on March 31, 2025.
  • Over the past year, TXG quarterly cash & cash equivalents has increased by +$21.28 million (+5.98%).
  • TXG quarterly cash & cash equivalents is now -50.95% below its all-time high of $768.77 million, reached on September 30, 2020.

Performance

TXG quarterly cash & cash equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTXGbalance sheet metrics

Cash and cash equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

TXG Cash and cash equivalents Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-4.2%+6.0%
3 y3 years-41.4%+20.7%
5 y5 years-18.9%+1.2%

TXG Cash and cash equivalents Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-41.4%+56.6%-5.3%+71.6%
5 y5-year-48.1%+56.6%-51.0%+71.6%
alltimeall time-48.1%+619.0%-51.0%+706.2%

TXG Cash and cash equivalents History

DateAnnualQuarterly
Mar 2025
-
$377.06M(+9.6%)
Dec 2024
$344.07M(-4.2%)
$344.07M(-13.6%)
Sep 2024
-
$398.16M(+4.8%)
Jun 2024
-
$379.82M(+6.8%)
Mar 2024
-
$355.78M(-1.0%)
Dec 2023
$359.28M(+63.5%)
$359.28M(+15.4%)
Sep 2023
-
$311.26M(-4.5%)
Jun 2023
-
$325.88M(-1.9%)
Mar 2023
-
$332.32M(+51.2%)
Dec 2022
$219.75M(-62.6%)
$219.75M(-6.1%)
Sep 2022
-
$233.95M(-14.7%)
Jun 2022
-
$274.19M(-12.3%)
Mar 2022
-
$312.49M(-46.8%)
Dec 2021
$587.45M(-11.5%)
$587.45M(-2.2%)
Sep 2021
-
$600.44M(-3.5%)
Jun 2021
-
$621.96M(+0.8%)
Mar 2021
-
$617.20M(-7.0%)
Dec 2020
$663.60M
$663.60M(-13.7%)
Sep 2020
-
$768.77M(+126.2%)
DateAnnualQuarterly
Jun 2020
-
$339.84M(-8.8%)
Mar 2020
-
$372.43M(-12.2%)
Dec 2019
$424.17M(+551.8%)
$424.17M(-0.8%)
Sep 2019
-
$427.44M(+662.8%)
Jun 2019
-
$56.03M(-13.9%)
Dec 2018
$65.08M(+36.0%)
$65.08M(-88.1%)
Dec 2017
$47.86M
-
Sep 2017
-
$546.40M(+862.7%)
Jun 2017
-
$56.76M(-2.5%)
Mar 2017
-
$58.23M(+0.9%)
Dec 2016
-
$57.70M(-15.2%)
Sep 2016
-
$68.07M(-36.0%)
Jun 2016
-
$106.35M(+11.3%)
Mar 2016
-
$95.58M(+104.4%)
Dec 2015
-
$46.77M(-84.2%)
Sep 2015
-
$296.37M(+21.0%)
Jun 2015
-
$244.93M(-2.1%)
Mar 2015
-
$250.13M(-33.0%)
Dec 2014
-
$373.14M

FAQ

  • What is 10x Genomics annual cash & cash equivalents?
  • What is the all time high annual cash & cash equivalents for 10x Genomics?
  • What is 10x Genomics annual cash & cash equivalents year-on-year change?
  • What is 10x Genomics quarterly cash & cash equivalents?
  • What is the all time high quarterly cash & cash equivalents for 10x Genomics?
  • What is 10x Genomics quarterly cash & cash equivalents year-on-year change?

What is 10x Genomics annual cash & cash equivalents?

The current annual cash & cash equivalents of TXG is $344.07M

What is the all time high annual cash & cash equivalents for 10x Genomics?

10x Genomics all-time high annual cash & cash equivalents is $663.60M

What is 10x Genomics annual cash & cash equivalents year-on-year change?

Over the past year, TXG annual cash & cash equivalents has changed by -$15.22M (-4.24%)

What is 10x Genomics quarterly cash & cash equivalents?

The current quarterly cash & cash equivalents of TXG is $377.06M

What is the all time high quarterly cash & cash equivalents for 10x Genomics?

10x Genomics all-time high quarterly cash & cash equivalents is $768.77M

What is 10x Genomics quarterly cash & cash equivalents year-on-year change?

Over the past year, TXG quarterly cash & cash equivalents has changed by +$21.28M (+5.98%)
On this page